B
Beth Lynn
Researcher at National Comprehensive Cancer Network
Publications - 2
Citations - 583
Beth Lynn is an academic researcher from National Comprehensive Cancer Network. The author has contributed to research in topics: Neuroendocrine tumors & Multiple endocrine neoplasia. The author has an hindex of 2, co-authored 2 publications receiving 74 citations.
Papers
More filters
Journal ArticleDOI
Pancreatic adenocarcinoma, Version 2.2021
Margaret A. Tempero,Mokenge P. Malafa,Mahmoud M. Al-Hawary,Stephen W. Behrman,Al B. Benson,Dana Backlund Cardin,E. Gabriela Chiorean,Vincent Chung,Brian G. Czito,Marco Del Chiaro,Mary Dillhoff,Timothy R. Donahue,Efrat Dotan,Cristina R. Ferrone,Christos Fountzilas,Jeffrey M. Hardacre,William G. Hawkins,Kelsey Klute,Andrew H. Ko,John W. Kunstman,Noelle K. LoConte,Andrew M. Lowy,Cassadie Moravek,Eric K. Nakakura,Amol Narang,Jorge Obando,Patricio M. Polanco,Sushanth Reddy,Marsha Reyngold,Courtney L. Scaife,Jeanne Shen,Charles M. Vollmer,Robert A. Wolff,Brian M. Wolpin,Beth Lynn,Giby V. George +35 more
Abstract: Pancreatic cancer is the fourth leading cause of cancer-related death among men and women in the United States. A major challenge in treatment remains patients' advanced disease at diagnosis. The NCCN Guidelines for Pancreatic Adenocarcinoma provides recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with pancreatic cancer. Although survival rates remain relatively unchanged, newer modalities of treatment, including targeted therapies, provide hope for improving patient outcomes. Sections of the manuscript have been updated to be concordant with the most recent update to the guidelines. This manuscript focuses on the available systemic therapy approaches, specifically the treatment options for locally advanced and metastatic disease.
Journal ArticleDOI
Neuroendocrine and adrenal tumors, version 2.2021
Manisha H. Shah,Whitney S. Goldner,Al B. Benson,Emily K. Bergsland,Lawrence S. Blaszkowsky,Pamela Brock,Jennifer A. Chan,Satya Das,Paxton V. Dickson,Paul T. Fanta,Thomas J. Giordano,Thorvardur R. Halfdanarson,Daniel M. Halperin,Jin He,Anthony P. Heaney,Martin J. Heslin,Fouad Kandeel,Arash Kardan,Sajid A. Khan,Boris W. Kuvshinoff,Christopher H. Lieu,Kimberly A. Miller,Venu G. Pillarisetty,Diane Lauren Reidy,Sarimar N Agosto Salgado,Shagufta Shaheen,Heloisa P. Soares,Michael C. Soulen,Jonathan R. Strosberg,Craig R. Sussman,Nikolaos A. Trikalinos,Nataliya Uboha,Namrata Vijayvergia,Terence Z. Wong,Beth Lynn,Cindy Hochstetler +35 more
TL;DR: The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Neuroendocrine and Adrenal Gland Tumors focus on the diagnosis, treatment, and management of patients with neuroendocrine tumors (NETs), adrenal tumors, pheochromocytomas, paragangliomas, and multiple endocrine neoplasia as mentioned in this paper.